| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Ustekinumab Anti-drug Antibody
Test Code18219
CPT Codes
82397 <br><strong>This test is not available for New York patient testing</strong>
Preferred Specimen
0.5 mL serum
Minimum Volume
0.35 mL
Instructions
Collect serum immediately before the next scheduled dose (trough specimen)
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 28 days
Refrigerated: 7 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderate and gross hemolysis
Methodology
Immunoassay (IA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues, Thurs, Sat; Report available: 3-5 days
Clinical Significance
Ustekinumab is a therapeutic monoclonal antibody against a shared subunit of the pro-inflammatory cytokines IL-12 and IL-23. It is used to treat psoriasis as well as moderate to severe ulcerative colitis and Crohn's disease. It is not significantly immunogenic and only a small percentage of treated patients develop antibodies. However, in these patients, antibodies may be associated with lower trough levels of the drug. Results >2 AU/mL indicate the presence of anti-drug antibody.

